Get an insider's perspective on what makes a viral vector clinically successful. Originally delivered as an interactive virtual workshop, this on-demand session—brought to you by Phacilitate in collaboration with ViroCell Biologics—features deep expertise from one of the industry’s most experienced vector design teams.

Led by Dr. Farzin Farzaneh and the ViroCell Biologics team, this session covers critical considerations in lentiviral vector optimization, addressing common challenges in translational development and clinical readiness. Whether you're facing titer issues, refining quality parameters, or tailoring your vector to specific tumor types, this session offers actionable guidance.

Key highlights include:
✔ Factors influencing vector design based on indication or tumor profile
✔ Strategies to overcome common challenges in achieving high titers
✔ Packaging plasmid considerations and quality control measures
✔ How intelligent design platforms can reduce risk in clinical programs

Watch now to gain practical insights from leading scientists on how to de-risk your vector design and move closer to clinical success.

Brought to you in collaboration with ViroCell Biologics.

Disclaimer:
This webinar is part of our legacy content, hosted on a previous platform. As a result, some interactive or engagement features may be limited.